Dicerna Pharma

Dicerna Pharma

Dicerna Pharma

Dicerna Pharmaceuticals is focused on the discovery and development ofinnovative treatments for rare inherited diseases.
Type
B2c
Founded
2007
Raised
$258M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
Team Size
1–10
Employees
Pulse 2.0 , MedCity News

Why Novo Nordisk (NVO) Is Buying Dicerna Pharmaceuticals (DRNA) For $3.3 Billion

Xconomy , MedCity News

Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug

$70,000,000 Post-IPO equity
PE HUB

Dicerna scores $70 mln

Funding Stock markets